Caterpillar Inc. (CAT) Shares Sold by OppenheimerFunds Inc.

OppenheimerFunds Inc. reduced its stake in shares of Caterpillar Inc. (NYSE:CAT) by 58.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 172,653 shares of the industrial products company’s stock after selling 245,295 shares during the quarter. OppenheimerFunds Inc.’s holdings in Caterpillar were worth $25,446,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in CAT. BlackRock Inc. raised its stake in Caterpillar by 6.5% during the 4th quarter. BlackRock Inc. now owns 37,565,629 shares of the industrial products company’s stock worth $5,919,590,000 after acquiring an additional 2,297,750 shares in the last quarter. Prudential Financial Inc. grew its position in Caterpillar by 99.6% during the 1st quarter. Prudential Financial Inc. now owns 1,990,874 shares of the industrial products company’s stock worth $293,415,000 after purchasing an additional 993,438 shares during the last quarter. Amundi Pioneer Asset Management Inc. purchased a new position in Caterpillar during the 4th quarter worth $148,604,000. Fred Alger Management Inc. purchased a new position in Caterpillar during the 4th quarter worth $103,179,000. Finally, TIAA CREF Investment Management LLC grew its position in Caterpillar by 17.7% during the 4th quarter. TIAA CREF Investment Management LLC now owns 4,035,424 shares of the industrial products company’s stock worth $635,902,000 after purchasing an additional 607,875 shares during the last quarter. Hedge funds and other institutional investors own 66.86% of the company’s stock.

Get Caterpillar alerts:

CAT stock opened at $155.32 on Friday. The stock has a market cap of $93.45 billion, a P/E ratio of 22.58, a P/E/G ratio of 1.10 and a beta of 1.32. Caterpillar Inc. has a 52 week low of $102.30 and a 52 week high of $173.24. The company has a current ratio of 1.36, a quick ratio of 0.96 and a debt-to-equity ratio of 1.52.

Caterpillar (NYSE:CAT) last released its quarterly earnings data on Tuesday, April 24th. The industrial products company reported $2.82 EPS for the quarter, topping analysts’ consensus estimates of $2.11 by $0.71. The firm had revenue of $12.86 billion for the quarter, compared to the consensus estimate of $11.99 billion. Caterpillar had a net margin of 4.59% and a return on equity of 34.38%. The firm’s revenue was up 30.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.28 earnings per share. equities analysts predict that Caterpillar Inc. will post 10.72 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Saturday, May 19th. Shareholders of record on Monday, April 23rd were given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date of this dividend was Friday, April 20th. Caterpillar’s payout ratio is currently 45.35%.

CAT has been the topic of several research reports. Vetr downgraded shares of Caterpillar from a “buy” rating to a “hold” rating and set a $166.15 price objective on the stock. in a research report on Monday, February 19th. Zacks Investment Research raised shares of Caterpillar from a “sell” rating to a “hold” rating in a research report on Monday, April 9th. Morgan Stanley initiated coverage on shares of Caterpillar in a research report on Friday, March 2nd. They set an “overweight” rating and a $185.00 price objective on the stock. OTR Global raised shares of Caterpillar to a “positive” rating in a research report on Monday, April 9th. Finally, UBS Group set a $190.00 price objective on shares of Caterpillar and gave the stock a “buy” rating in a research report on Thursday, February 15th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $172.55.

In other Caterpillar news, Director David L. Calhoun bought 5,000 shares of the business’s stock in a transaction on Monday, May 14th. The stock was bought at an average price of $155.37 per share, for a total transaction of $776,850.00. Following the completion of the transaction, the director now owns 19,579 shares in the company, valued at approximately $3,041,989.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas A. Pellette sold 54,481 shares of Caterpillar stock in a transaction dated Monday, May 7th. The stock was sold at an average price of $150.17, for a total transaction of $8,181,411.77. The disclosure for this sale can be found here. Insiders own 0.36% of the company’s stock.

Caterpillar Profile

Caterpillar Inc manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives for construction, resource, and energy and transportation industries. Its Construction Industries segment offers asphalt pavers, backhoe loaders, compactors, cold planers, compact truck and multi-terrain loaders, forestry excavators, feller bunchers, harvesters, knuckleboom loaders, motorgraders, pipelayers, road reclaimers, site prep tractors, skidders, skid steer loaders, telehandlers, track-type loaders, wheel excavators, and track-type tractors.

Want to see what other hedge funds are holding CAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Caterpillar Inc. (NYSE:CAT).

Institutional Ownership by Quarter for Caterpillar (NYSE:CAT)

aTyr Pharma (LIFE) Trading 19.1% Higher

Shares of aTyr Pharma, Inc. (NASDAQ:LIFE) traded up 19.1% during mid-day trading on Friday . The stock traded as high as $0.97 and last traded at $1.12. 189,107 shares were traded during trading, a decline of 71% from the average session volume of 645,140 shares. The stock had previously closed at $0.94.

Several analysts have issued reports on the company. Zacks Investment Research cut aTyr Pharma from a “buy” rating to a “hold” rating in a research note on Friday, March 30th. Piper Jaffray Companies restated an “overweight” rating and set a $3.00 price objective on shares of aTyr Pharma in a research note on Monday, May 14th. ValuEngine upgraded aTyr Pharma from a “sell” rating to a “hold” rating in a research note on Saturday, June 2nd. Citigroup cut aTyr Pharma from a “neutral” rating to a “sell” rating in a research note on Monday, May 14th. Finally, JPMorgan Chase & Co. cut aTyr Pharma from a “neutral” rating to an “underweight” rating in a research note on Wednesday, February 14th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. aTyr Pharma currently has a consensus rating of “Hold” and a consensus price target of $3.33.

Get aTyr Pharma alerts:

The firm has a market cap of $25.20 million, a P/E ratio of -0.55 and a beta of 3.20. The company has a quick ratio of 6.90, a current ratio of 6.90 and a debt-to-equity ratio of 0.24.

aTyr Pharma (NASDAQ:LIFE) last posted its earnings results on Monday, March 19th. The biotechnology company reported ($0.39) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.43) by $0.04. sell-side analysts predict that aTyr Pharma, Inc. will post -1.18 EPS for the current fiscal year.

In other news, major shareholder Ecor1 Capital Fund Qualified, sold 3,209,316 shares of the company’s stock in a transaction that occurred on Wednesday, May 16th. The stock was sold at an average price of $0.93, for a total transaction of $2,984,663.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Paul Schimmel bought 150,000 shares of the stock in a transaction dated Friday, May 18th. The shares were bought at an average cost of $1.00 per share, with a total value of $150,000.00. The disclosure for this purchase can be found here. 25.00% of the stock is currently owned by corporate insiders.

Several large investors have recently bought and sold shares of the company. Sofinnova Ventures Inc bought a new position in shares of aTyr Pharma during the first quarter valued at approximately $4,945,000. Dimensional Fund Advisors LP grew its holdings in shares of aTyr Pharma by 33.5% during the first quarter. Dimensional Fund Advisors LP now owns 114,449 shares of the biotechnology company’s stock valued at $303,000 after purchasing an additional 28,699 shares during the last quarter. Deutsche Bank AG bought a new position in shares of aTyr Pharma during the fourth quarter valued at approximately $199,000. Renaissance Technologies LLC grew its holdings in aTyr Pharma by 143.2% in the 4th quarter. Renaissance Technologies LLC now owns 279,400 shares of the biotechnology company’s stock worth $978,000 after buying an additional 164,500 shares in the last quarter. Finally, Artal Group S.A. grew its holdings in aTyr Pharma by 100.0% in the 4th quarter. Artal Group S.A. now owns 500,000 shares of the biotechnology company’s stock worth $1,750,000 after buying an additional 250,000 shares in the last quarter. 64.59% of the stock is owned by institutional investors.

aTyr Pharma Company Profile

aTyr Pharma, Inc, a clinical stage biotechnology company, engages in the discovery and development of medicines for the treatment of cancer and lung disease in the United States. The company's therapeutic candidate pipeline that includes ATYR1923 candidate, an agonist of the Resokine pathway that is in Phase I clinical trial designed to temper immune engagement in interstitial lung diseases; and ORCA program, a preclinical research stage program that targets immuno-oncology pathway using antibodies to enhance the immune response in tumor settings.

Forbes – Investing Information and Investing News – Forbes.com”,”description”:”Forbes is a leading s

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-918136588&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/918136588/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; (Photo Illustration by Thomas Trutschel/Photothek via Getty Images)

&l;a href=&q;http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=snap&a;amp;tab=searchtabquotesdark&q; target=&q;_blank&q;&g;Snap Inc.&l;/a&g; stock has underperformed the market for much of this year, due to the app redesign that caused a significant user backlash, weaker than expected Q1 results and slower projected growth for Q2. However, the stock rallied over the past week, rising from levels of about $10.50 to around $13, marking an increase of close to 25% (though it declined Thursday morning after an announced expansion in video by &l;a href=&q;http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=fb&a;amp;tab=searchtabquotesdark&q; target=&q;_blank&q;&g;Facebook&a;rsquo;s&l;/a&g; Instagram). Below, we take a look at some of the key factors that were likely behind the recent the rally in Snap&a;rsquo;s stock price.

We have also created an&a;nbsp;&l;strong&g;&l;a href=&q;http://dashboards.trefis.com/no-login-required/Ro7OWOI2?fromforbesandarticle=whats-driven-the-recent-volatility-in-snaps-stock&q; target=&q;_blank&q;&g;interactive analysis&l;/a&g;&a;nbsp;&l;/strong&g;outlining our expectations for Snap over 2018. You can modify the drivers to arrive at your own price estimate for Snap, and see how &l;a href=&q;http://www.trefis.com?fromforbesandarticle=whats-driven-the-recent-volatility-in-snaps-stock&q; target=&q;_blank&q;&g;institutional investors, CFOs and private equity firms&l;/a&g; use our technology.

&l;strong&g;Positive Reports On Snap&l;/strong&g;

Last week, research firm Citron Research published a bullish note on Snap, assigning the stock a 12-month price target of $17, indicating that it could see a return of about 30% from Wednesday&a;rsquo;s close. This is well ahead of projected returns of FANG stocks. The report also indicated that Snap could be a takeover target. Another report from Pew Research indicated that &l;a href=&q;https://www.bloomberg.com/news/articles/2018-05-31/america-s-teens-are-choosing-youtube-over-facebook&q; target=&q;_blank&q;&g;Snap was now&l;/a&g; more popular than its rival Facebook with teenagers in the U.S. As teenagers are typically harder for marketers to reach, this could make Snap&a;rsquo;s ad inventory relatively valuable.

&l;b&g;Snap Is Looking To Undo The Damage Of The Redesign&l;/b&g;

There could be other factors at play as well. Over the last few weeks, Snap has been rolling out a new version of the Snapchat app that attempts to fix many of the user interface issues that plagued the major redesign the company unveiled late last year. The redesign didn&a;rsquo;t go down well with core users, who found the UI changes unintuitive. With the new update, Snap is addressing key issues, including repositioning the Stories page to the right of the main Camera screen, while ordering Snaps and Chats chronologically (rather than algorithmically) on the Friends page.

&l;a href=&q;http://dashboards.trefis.com/no-login-required/Ro7OWOI2?fromforbesandarticle=whats-driven-the-recent-volatility-in-snaps-stock&q; target=&q;_blank&q;&g;&l;img class=&q; wp-image-184954 size-full&q; src=&q;http://blogs-images.forbes.com/greatspeculations/files/2018/06/Snap_America_1.jpg?width=960&q; alt=&q;&q; data-height=&q;342&q; data-width=&q;757&q;&g;&l;/a&g;

&l;b&g;Short Covering May Also Be A Factor&l;/b&g;

Short selling has also contributed to Snap&a;rsquo;s underperformance over the year, with short interest &l;a href=&q;https://www.businessinsider.in/Snap-was-oversold-after-its-disastrous-earnings-now-its-up-16-in-4-days/articleshow/64455247.cms&q; target=&q;_blank&q;&g;accounting for 21.3%&l;/a&g; of the company free float as of last Friday. It&a;rsquo;s possible that the recent positive news surrounding the company is causing some short sellers to cover their positions fearing a short squeeze, pushing the stock higher.

&l;!–donotpaginate–&g;

Like our charts? Explore &l;a href=&q;https://dashboards.trefis.com/signupDashboard&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;example interactive dashboards&l;/a&g; and create your own.&l;/p&g;

Here's Why Incyte Rose 10.2% in May

What happened

Shares of recently struggling biopharma Incyte (NASDAQ:INCY) finally turned in a positive performance in May, gaining over 10% last month, according to data provided by S&P Global Market Intelligence. That was a welcomed reprieve for shareholders that have endured a steady stream of disappointing updates from the clinic, including the spectacular phase 3 fail of the combination therapy of epacadostat and Keytruda at the end of April.

The stock’s ascension was catalyzed by solid first-quarter 2018 results and a decision by the U.S. Food and Drug Administration to approve the use of Olumiant in treating rheumatoid arthritis, which could deliver peak sales of $2.5 billion if expanded further. Considering Incyte has double-digit royalties on sales from partner Eli Lilly, the approval has caught the attention of investors.

Several lines on a chalk board with a positive slope.

Image source: Getty Images.

So what

A logjam of bad news has cut Incyte’s market cap in half in the last year, from a peak of $28 billion to just $14.6 billion today. Then again, that still makes this a sizable biopharma. Healthy sales growth from its blockbuster Jakafi certainly helps. The drug posted $314 million in revenue in the first quarter of 2018, which represented a 25% increase from the year-ago period.

And despite numerous clinical failures in recent years, investors haven’t lost complete faith in the company’s pipeline. In 2018, Jakafi is expected to deliver results from multiple trials evaluating the drug as a potential treatment for graft-versus-host disease. Success has the potential to greatly expand the blockbuster’s sales footprint. Meanwhile, epacadostat is being evaluated in multiple clinical trials that remain ongoing, so its recent failure may not completely wipe out the once-promising drug candidate’s future.

Now what

Even when including the strong showing from May, Incyte stock is still down 43.5% in the last year. However, the company could be a more attractive investment at its current market cap of around $15 billion. Rapidly expanding sales of Jakafi and the recent U.S. approval of Olumiant in rheumatoid arthritis could make this a solidly profitable business in a few years’ time.

Does management think that’s a realistic possibility? Investors might find out later this month, when the latest pipeline updates and development strategy are announced at the company-hosted investor and analyst event on June 21.

Hot Cheap Stocks To Buy For 2019

Related TSLA Fake Metrics To Fake Accounts: 2016's Big Corporate Scandals A Sampling Of Citron's Most Influential Tweets The New Tesla: The Elon Musk Medicine Show (Seeking Alpha)

Solar stocks have established the tendency over the years of disappointing investors. The name SunEdison still haunts investors, as one of the world’s biggest solar power companies declared bankruptcy in 2016. Tesla Motors Inc (NASDAQ: TSLA)’s acquisition of its sister company SolarCity was viewed by many as being a “bail-out” of the troubled solar energy company.

Despite the well-known troubles of many of the most notable global solar companies, solar power is now a cheaper power-generating alternative in many countries compared to coal.

Hot Cheap Stocks To Buy For 2019: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By Matt Hogan]

    Growth within the industry is a bit lumpy, with limited-service restaurants, such as Wendys Co (NASDAQ: WEN) and Chipotle Mexican Grill, Inc (NYSE: CMG), growing at 5.3 percent in 2017 as compared to 3.5 percent for casual dining establishments according to the National Restaurant Industry.

  • [By Logan Wallace]

    Wendy’s (NASDAQ:WEN) major shareholder Edward P. Garden sold 764,000 shares of the business’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $16.53, for a total value of $12,628,920.00. Following the completion of the sale, the insider now directly owns 240,365 shares of the company’s stock, valued at approximately $3,973,233.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Shane Hupp]

    Wendy’s (NASDAQ:WEN)‘s stock had its “buy” rating reiterated by equities researchers at Argus in a research note issued to investors on Thursday. They currently have a $16.34 price target on the restaurant operator’s stock, down from their prior price target of $19.00.

Hot Cheap Stocks To Buy For 2019: Express-1 Expedited Solutions Inc.(XPO)

Advisors’ Opinion:

  • [By Logan Wallace]

    XPO Logistics (NYSE:XPO)‘s stock had its “buy” rating reissued by research analysts at Bank of America in a research note issued on Friday. They presently have a $105.00 target price on the transportation company’s stock. Bank of America’s price objective would indicate a potential upside of 4.86% from the stock’s previous close.

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer said XPO Logistics (XPO) is a remarkable company.

    Cramer said UPS (UPS) has labor problems and people think FedEx (FDX) is expensive. “XPO has got a lot of things that they can do,” Cramer said. “They’re in M&A mode.”

  • [By ]

    Daseke (DSKE) : “I’m going to send you to XPO Logistics (XPO) . That’s the one you want to be in.”

    Portola Pharmaceuticals (PTLA) : “The news is already in this story. I’d rather be in something better.”

  • [By Steve Symington, Jeremy Bowman, and Demitrios Kalogeropoulos]

    So we asked that question to three top Motley Fool investors. Read on to learn why they put New Relic (NYSE:NEWR), XPO Logistics (NYSE:XPO), and Ebay (NASDAQ:EBAY)on their short lists of stocks capable of outperforming a five-bagger.

Hot Cheap Stocks To Buy For 2019: USG Corporation(USG)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

Hot Cheap Stocks To Buy For 2019: S&P GSCI(GD)

Advisors’ Opinion:

  • [By ]

    Cramer and Moreno also looked at General Dynamics (GD) which peaked in early March, before starting a downtrend until Tuesday. Last week, General Dynamics fell to the lower end of its channel, but then it bounced right to the high end, and Wednesday it firmly broke out above the high end of this channel. The stochastic oscillator, which is a powerful momentum indicator is making a bullish crossover, and based on today’s move, Moreno thinks General Dynamics can return to its old highs at $230.

  • [By Logan Wallace]

    These are some of the headlines that may have effected Accern’s analysis:

    Get General Dynamics alerts:

    U.S. Air Force Awards General Dynamics Cloud Services Contract (finance.yahoo.com) General Dynamics (GD) Receives Average Recommendation of “Buy” from Analysts (americanbankingnews.com) America Desperately Needs More Submarines. And That Is Good News for General Dynamics. (yahoo.com) GD completes Hawker Pacific acquisition (janes.com) General Dynamics Unit Secures Work for Aircraft Computer System Repairs, Replacement (govconwire.com)

    Shares of NYSE:GD traded up $3.17 on Tuesday, reaching $199.62. The company’s stock had a trading volume of 2,149,954 shares, compared to its average volume of 1,720,029. General Dynamics has a 52-week low of $190.30 and a 52-week high of $230.00. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.98 and a current ratio of 1.34. The stock has a market capitalization of $57.94 billion, a price-to-earnings ratio of 20.06, a PEG ratio of 1.89 and a beta of 0.84.

  • [By Reuben Gregg Brewer]

    Shipbuilding and services specialistHuntington Ingalls (NYSE:HII) was spun off from Northup Grumman in early 2011. General Dynamics (NYSE:GD) is roughly six times larger and offers a far more diversified list of products and services that includes submarines, aircraft, and armored vehicles, among other things. Both, however, provide key products and services to the U.S. military. That’s normally a fairly consistent business driven by large and often very long contracts. With a supportive administration in the White House, it would seem like now is a good time to take a look at this pair of stocks. But which of these two military-industrial companies is a better buy? Using a Benjamin Grahamlens, the answer may not be what you want to hear.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By ]

    Finally, General Dynamics Corp. (GD) , along with Lockheed and BAE Systems, could possibly profit from heightened demand ships and other vehicles. 

  • [By ]

    Moreno was also upbeat on General Dynamics (GD) , which just made a bullish crossover, but felt that Raytheon had the best chart of them all.

    Cramer agreed, saying he’s bullish on all of these names.

Hot Cheap Stocks To Buy For 2019: Sirius XM Radio Inc.(SIRI)

Advisors’ Opinion:

  • [By Chris Hill]

    Lastly, the Fools answer a classic question from a listener: “When should an investor start taking profits on a multibagger stock? Or should he just hold on forever?” Since the answer to this depends a lot on the company, they both talk generally and address the case of the listener’s stock –Sirius XM (NASDAQ:SIRI)– which is up around 500% since he bought it.

  • [By Joseph Griffin]

    Toronto Dominion Bank raised its position in shares of Sirius XM Holdings Inc (NASDAQ:SIRI) by 36.7% in the first quarter, HoldingsChannel.com reports. The fund owned 130,110 shares of the company’s stock after buying an additional 34,955 shares during the quarter. Toronto Dominion Bank’s holdings in Sirius XM were worth $812,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Rick Munarriz]

    Shares of Sirius XM Holdings (NASDAQ:SIRI)hit a new 12-year high of $7.08 this week, and in terms of market cap the satellite radio provider has never been as valuable as it is right now. The market darling hasn’t traded this high since late 2005, and it’s fair to say that this was an entirely different company back then. Sirius had yet to merge with XM. The share count was substantially lower.

  • [By Rick Munarriz]

    There are two ways to buy into the country’s lone provider of satellite radio, and one Wall Street pro thinks you should consider the road less traveled. Buckingham analyst Matthew Harrigan is downgrading shares of Sirius XM Holdings (NASDAQ:SIRI) on Monday, lowering his rating from buy to neutral.

  • [By ]

    Berkshire’s biggest winners in the stock market so far this year are MasterCard Inc. (MA) , up 23%; Sirius XM Holdings Inc. (SIRI) , up 18%; Phillips 66 (PSX) , up 14%; Visa Inc. (V) , up 11%; and Moody’s Corp. (MCO) , also up 11%, according to FactSet.

  • [By Joseph Griffin]

    Swiss National Bank cut its position in Sirius XM Holdings (NASDAQ:SIRI) by 13.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,157,758 shares of the company’s stock after selling 818,600 shares during the period. Swiss National Bank owned about 0.11% of Sirius XM worth $32,184,000 as of its most recent filing with the Securities and Exchange Commission (SEC).